Abstract
The extent to which dengue virus has been circulating globally and especially in Africa is largely unknown. Testing available blood samples from previous cross-sectional serological surveys offers a convenient strategy to investigate past dengue infections, as such serosurveys provide the ideal data to reconstruct the age-dependent immunity profile of the population and to estimate the average per-capita annual risk of infection: the force of infection (FOI), which is a fundamental measure of transmission intensity. In this study, we present a novel methodological approach to inform the size and age distribution of blood samples to test when samples are acquired from previous surveys. The method was used to inform SERODEN, a dengue seroprevalence survey which is currently being conducted in Ghana among other countries utilizing samples previously collected for a SARS-CoV-2 serosurvey. The method described in this paper can be employed to determine sample sizes and testing strategies for different diseases and transmission settings.
All Related Versions
Funding Information
  • Drugs for Neglected Diseases initiative (reference MR/X020258/1)
  • Foundation BLANCEFLOR Boncompagni Ludovisi
  • Wellcome Trust (213494/Z/18/Z)
  • UK National Institute for Health and Care Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections in partnership with Public Health England (HPRU200907)
  • French Development Agency
  • Médecins sans Frontières International
  • Swiss Agency for Development and Cooperation
  • UK Aid

This publication has 26 references indexed in Scilit: